NovoCure Ltd (NVCR)
12.24
-0.50
(-3.92%)
USD |
NASDAQ |
May 02, 09:59
NovoCure Debt to Equity Ratio: 1.569 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 1.569 |
September 30, 2023 | 1.443 |
June 30, 2023 | 1.364 |
March 31, 2023 | 1.310 |
December 31, 2022 | 1.282 |
September 30, 2022 | 1.268 |
June 30, 2022 | 1.277 |
March 31, 2022 | 1.292 |
December 31, 2021 | 1.370 |
September 30, 2021 | 1.359 |
June 30, 2021 | 1.411 |
March 31, 2021 | 1.504 |
December 31, 2020 | 0.9022 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.5582 |
March 31, 2020 | 0.6178 |
December 31, 2019 | 0.6861 |
September 30, 2019 | 0.7847 |
June 30, 2019 | 0.9398 |
Date | Value |
---|---|
March 31, 2019 | 1.181 |
December 31, 2018 | 1.330 |
September 30, 2018 | 1.298 |
June 30, 2018 | 1.331 |
March 31, 2018 | 1.406 |
December 31, 2017 | 0.8626 |
September 30, 2017 | 0.8317 |
June 30, 2017 | 0.8232 |
March 31, 2017 | 0.7486 |
December 31, 2016 | 0.6798 |
September 30, 2016 | 0.6065 |
June 30, 2016 | 0.1248 |
March 31, 2016 | 0.1052 |
December 31, 2015 | 0.0921 |
September 30, 2015 | 0.2026 |
June 30, 2015 | 0.17 |
March 31, 2015 | |
December 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Sep 2020
1.569
Maximum
Dec 2023
1.102
Average
1.282
Median
Dec 2022
Debt to Equity Ratio Benchmarks
AtriCure Inc | 0.1354 |
NeuroMetrix Inc | 0.00 |
Repligen Corp | 0.294 |
Teleflex Inc | 0.4087 |
Perspective Therapeutics Inc | 0.0229 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 1.146B |
Total Liabilities (Quarterly) | 783.63M |
Shareholders Equity (Quarterly) | 362.50M |
Current Ratio | 5.775 |
Net Debt Paydown Yield | -0.05% |